314 related articles for article (PubMed ID: 9053471)
21. Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations.
Pilz G; Fraunberger P; Appel R; Kreuzer E; Werdan K; Walli A; Seidel D
Crit Care Med; 1996 Apr; 24(4):596-600. PubMed ID: 8612409
[TBL] [Abstract][Full Text] [Related]
22. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.
Warzocha K; Ribeiro P; Bienvenu J; Roy P; Charlot C; Rigal D; Coiffier B; Salles G
Blood; 1998 May; 91(10):3574-81. PubMed ID: 9572991
[TBL] [Abstract][Full Text] [Related]
23. Plasma patterns of tumor necrosis factor-alpha (TNF) and TNF soluble receptors during acute meningococcal infections and the effect of plasma exchange.
van Deuren M; Frieling JT; van der Ven-Jongekrijg J; Neeleman C; Russel FG; van Lier HJ; Bartelink AK; van der Meer JW
Clin Infect Dis; 1998 Apr; 26(4):918-23. PubMed ID: 9564476
[TBL] [Abstract][Full Text] [Related]
24. Assessment of prognostic factors in follicular lymphoma patients.
Kondo E; Ogura M; Kagami Y; Taji H; Miura K; Takeuchi T; Maeda S; Asakura S; Suzuki R; Nakamura S; Morishima Y
Int J Hematol; 2001 Apr; 73(3):363-8. PubMed ID: 11345204
[TBL] [Abstract][Full Text] [Related]
25. Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas.
Warzocha K; Ribeiro P; Renard N; Bienvenu J; Charlot C; Coiffier B; Salles G
Cancer Immunol Immunother; 2000 Nov; 49(9):469-75. PubMed ID: 11092613
[TBL] [Abstract][Full Text] [Related]
26. Plasma TNF-alpha and IL-10 level-based prognostic model predicts outcome of patients with diffuse large B-Cell lymphoma in different risk groups defined by the International Prognostic Index.
Lech-Maranda E; Bienvenu J; Broussais-Guillaumot F; Warzocha K; Michallet AS; Robak T; Coiffier B; Salles G
Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):131-41. PubMed ID: 20191326
[TBL] [Abstract][Full Text] [Related]
27. Elevated serum levels of soluble CD44 variant 6 are correlated with shorter survival in aggressive non-Hodgkin's lymphoma.
Sasaki K; Niitsu N
Eur J Haematol; 2000 Sep; 65(3):195-202. PubMed ID: 11007056
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
29. Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome.
Juszczynski P; Kalinka E; Bienvenu J; Woszczek G; Borowiec M; Robak T; Kowalski M; Lech-Maranda E; Baseggio L; Coiffier B; Salles G; Warzocha K
Blood; 2002 Oct; 100(8):3037-40. PubMed ID: 12351419
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor (TNF)-alpha-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptors.
Frishman JI; Edwards CK; Sonnenberg MG; Kohno T; Cohen AM; Dinarello CA
J Infect Dis; 2000 Dec; 182(6):1722-30. PubMed ID: 11069245
[TBL] [Abstract][Full Text] [Related]
31. Serum cholesterol levels in neutropenic patients with fever.
Fraunberger P; Hahn J; Holler E; Walli AK; Seidel D
Clin Chem Lab Med; 2002 Mar; 40(3):304-7. PubMed ID: 12005222
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
[TBL] [Abstract][Full Text] [Related]
33. Obesity and diabetes in TNF-alpha receptor- deficient mice.
Schreyer SA; Chua SC; LeBoeuf RC
J Clin Invest; 1998 Jul; 102(2):402-11. PubMed ID: 9664082
[TBL] [Abstract][Full Text] [Related]
34. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma.
Bonnet C; Beguin Y; Fassotte MF; Seidel L; Luyckx F; Fillet G
Eur J Haematol; 2007 May; 78(5):399-404. PubMed ID: 17419741
[TBL] [Abstract][Full Text] [Related]
35. Cost determinants in aggressive non-Hodgkin's lymphoma.
van Agthoven M; Sonneveld P; Verdonck LF; Uyl-de Groot CA
Haematologica; 2005 May; 90(5):661-71. PubMed ID: 15921381
[TBL] [Abstract][Full Text] [Related]
36. Altered release of tumor necrosis factor and its soluble receptor in non-Hodgkin's lymphoma patients.
Rathore VB; Advani SH; Nadkarni JJ
Cancer Detect Prev; 1999; 23(3):226-31. PubMed ID: 10337001
[TBL] [Abstract][Full Text] [Related]
37. Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis.
Gattorno M; Picco P; Buoncompagni A; Stalla F; Facchetti P; Sormani MP; Pistoia V
Ann Rheum Dis; 1996 Apr; 55(4):243-7. PubMed ID: 8733441
[TBL] [Abstract][Full Text] [Related]
38. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.
Peschon JJ; Torrance DS; Stocking KL; Glaccum MB; Otten C; Willis CR; Charrier K; Morrissey PJ; Ware CB; Mohler KM
J Immunol; 1998 Jan; 160(2):943-52. PubMed ID: 9551933
[TBL] [Abstract][Full Text] [Related]
39. Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma.
Nowak J; Kalinka-Warzocha E; Juszczynski P; Bilinski P; Mika-Witkowska R; Zajko M; Bienvenu J; Coiffier B; Salles G; Warzocha K
Genes Chromosomes Cancer; 2007 May; 46(5):500-7. PubMed ID: 17311253
[TBL] [Abstract][Full Text] [Related]
40. An improved prognostic parameter for non-Hodgkin's lymphoma based on the combination of three serum tumor markers.
Gui W; Wang T; Wang J; Wang L; He J; Yang B; Zhao Z; Zhang H; Zhang Q
Int J Biol Markers; 2008; 23(4):207-13. PubMed ID: 19199267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
